Emerging evidence for a central epinephrine-innervated alpha 1-adrenergic system that regulates behavioral activation and is impaired in depression.
Currently, most basic and clinical research on depression is focused on either central serotonergic, noradrenergic, or dopaminergic neurotransmission as affected by various etiological and predisposing factors. Recent evidence suggests that there is another system that consists of a subset of brain alpha(1B)-adrenoceptors innervated primarily by brain epinephrine (EPI) that potentially modulates the above three monoamine systems in parallel and plays a critical role in depression. The present review covers the evidence for this system and includes findings that brain alpha(1)-adrenoceptors are instrumental in behavioral activation, are located near the major monoamine cell groups or target areas, receive EPI as their neurotransmitter, are impaired or inhibited in depressed patients or after stress in animal models, and are restored by a number of antidepressants. This "EPI-alpha(1) system" may therefore represent a new target system for this disorder.
Stone
Eric A
EA
Departments of Psychiatry and Neurology, New York University School of Medicine, NYU Medical Center, 550 First Avenue, New York, NY 10016, USA. es35@nyu.edu
Lin
Yan
Y
Rosengarten
Helen
H
Kramer
H Kenneth
HK
Quartermain
David
D
D000818:Animals; D001519:Behavior / Q000502:physiology*; D003863:Depression / Q000503:physiopathology*; D004837:Epinephrine / Q000502:physiology*; D006801:Humans; D009434:Neural Pathways / Q000502:physiology; D018340:Receptors, Adrenergic, alpha-1 / Q000502:physiology*
D018340:Receptors, Adrenergic, alpha-1; D004837:Epinephrine